Navellier & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.8M | Sell |
|
|||||
|
2025
Q1 | $20.2M | Sell |
|
|||||
|
2024
Q4 | $20.1M | Buy |
|
|||||
|
2024
Q3 | $22.1M | Sell |
|
|||||
|
2024
Q2 | $24.2M | Buy |
|
|||||
|
2024
Q1 | $19.9M | Buy |
|
|||||
|
2023
Q4 | $14.1M | Buy |
|
|||||
|
2023
Q3 | $11.7M | Buy |
|
|||||
|
2023
Q2 | $5.97M | Sell |
|
|||||
|
2023
Q1 | $4.48M | Sell |
|
|||||
|
2022
Q4 | $6.13M | Sell |
|
|||||
|
2022
Q3 | $5.69M | Sell |
|
|||||
|
2022
Q2 | $5.83M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $374K | Sell |
|
|||||
|
2020
Q4 | $355K | Hold |
|
|||||
|
2020
Q3 | $311K | Hold |
|
|||||
|
2020
Q2 | $345K | Sell |
|
|||||
|
2020
Q1 | $305K | Buy |
|
|||||
|
2019
Q4 | $263K | Buy |
|
|||||
|
2019
Q3 | $201K | Sell |
|
|||||
|
2019
Q2 | $211K | Buy |
|
|||||
|
2019
Q1 | $234K | Sell |
|
|||||
|
2018
Q4 | $220K | Sell |
|
|||||
|
2018
Q3 | $229K | Sell |
|
|||||
|
2018
Q2 | $205K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $297K | Sell |
|
|||||
|
2017
Q3 | $874K | Sell |
|
|||||
|
2017
Q2 | $1.28M | Sell |
|
|||||
|
2017
Q1 | $1.37M | Sell |
|
|||||
|
2016
Q4 | $1.24M | Sell |
|
|||||
|
2016
Q3 | $1.41M | Sell |
|
|||||
|
2016
Q2 | $1.44M | Buy |
|
|||||
|
2016
Q1 | $1.28M | Buy |
|
|||||
|
2015
Q4 | $1.47M | Buy |
|
|||||
|
2015
Q3 | $1.2M | Buy |
|
|||||
|
2015
Q2 | $298K | Buy |
|